LIMES Schlosskliniken AG (ETR:LIK)
570.00
0.00 (0.00%)
Aug 5, 2026, 9:02 AM CET
LIMES Schlosskliniken AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.31 | 10.88 | 8.52 | 10.93 | 2.48 |
Cash & Short-Term Investments | 10.31 | 10.88 | 8.52 | 10.93 | 2.48 |
Cash Growth | -5.22% | 27.74% | -22.03% | 339.79% | -7.43% |
Accounts Receivable | 8.59 | 5 | 4.54 | 3.06 | 2.64 |
Other Receivables | 0.48 | 1.76 | 1.55 | 1.29 | 0.58 |
Total Trade Receivables | 9.07 | 6.76 | 6.09 | 4.34 | 3.22 |
Inventory | 0.08 | 0.09 | 0.08 | 0.08 | 0.01 |
Other Current Assets | 0.23 | 0.51 | 0.34 | 0.23 | 0.31 |
Total Current Assets | 19.69 | 18.23 | 15.04 | 11.16 | 2.79 |
Net Property, Plant & Equipment | 18.25 | 11.58 | 7.93 | 2.56 | 2.7 |
Other Intangible Assets | 0.44 | 0.47 | 0.5 | 0.09 | 0.09 |
Goodwill | 6.78 | 8.28 | 9.79 | 8.41 | 9.63 |
Total Assets | 45.17 | 38.56 | 33.25 | 26.65 | 18.44 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.45 | 2.49 | 1.65 | 0.6 | 0.76 |
Accrued Expenses | 2.3 | 0.78 | 0.57 | 0.62 | 0.29 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 |
Unearned Revenue | 0.01 | 0 | 0.04 | 0 | 0.03 |
Other Current Liabilities | 3.31 | 2.99 | 2.12 | 2.01 | 0.88 |
Total Current Liabilities | 4.77 | 5.47 | 3.82 | 2.72 | 1.66 |
Long-Term Debt | 10.73 | 10.48 | 10.09 | 9.04 | 4.33 |
Other Long-Term Liabilities | 0.55 | 1.99 | 2.12 | 3.18 | 5.84 |
Total Long-Term Liabilities | 11.27 | 12.46 | 12.21 | 12.22 | 10.18 |
Total Liabilities | 16.05 | 17.94 | 16.03 | 14.93 | 11.84 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.3 | 0.29 | 0.29 | 0.29 | 0.29 |
Additional Paid-in Capital | 7.97 | 7.54 | 7.53 | 7.41 | 7.41 |
Retained Earnings | 17.05 | 10.5 | 7.31 | 3.4 | -1.49 |
Total Common Shareholders' Equity | 25.31 | 18.33 | 15.13 | 11.1 | 6.21 |
Minority Interest | 1.51 | 1.51 | 1.51 | 0.09 | 0.09 |
Shareholders' Equity | 26.83 | 19.84 | 16.64 | 11.2 | 6.31 |
Total Liabilities & Equity | 45.17 | 38.56 | 33.25 | 26.65 | 18.44 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 10.73 | 10.48 | 10.09 | 9.04 | 4.33 |
Net Cash (Debt) | -0.42 | 0.4 | -1.57 | 1.89 | -1.85 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -1.40 | 1.38 | -5.36 | 6.44 | -6.31 |
Book Value | 25.31 | 18.33 | 15.13 | 11.1 | 6.21 |
Book Value Per Share | 84.95 | 62.52 | 51.60 | 37.86 | 21.20 |
Tangible Book Value | 18.09 | 9.57 | 4.85 | 2.6 | -3.5 |
Tangible Book Value Per Share | 60.70 | 32.66 | 16.53 | 8.86 | -11.95 |